SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 12, 2008, Pages 1815-1817

Calculating clinically relevant drug doses to use in animal studies

(9) Fuchs, R K a Allen, M R a Condon, K W a Reinwald, S a Miller, L M b McClenathan, D c Keck, B c Phipps, R J c Burr, D B a

a INDIANA UNIVERSITY (United States)

b BROOKHAVEN NATIONAL LABORATORY (United States)

c PROCTER AND GAMBLE PHARMACEUTICALS (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; STRONTIUM RANELATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY MASS; CALCIUM DEFICIENCY; DOSE CALCULATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HUMAN; LETTER; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT;

EID: 55049132222 PISSN: 0937941X EISSN: 14332965 Source Type: Journal
DOI: 10.1007/s00198-008-0741-9 Document Type: Letter

Times cited : (11)

References (9)

1
- 49549101612
- Strontium ranelate does not stimulate bone formation in ovariectomized rats
- RK Fuchs MR Allen KW Condon S Reinwald LM Miller D McClenathan B Keck RJ Phipps DB Burr 2008 Strontium ranelate does not stimulate bone formation in ovariectomized rats Osteoporos Int 19 1331 1341
- (2008) Osteoporos Int , vol.19 , pp. 1331-1341
- Fuchs, R.K.¹ Allen, M.R.² Condon, K.W.³ Reinwald, S.⁴ Miller, L.M.⁵ McClenathan, D.⁶ Keck, B.⁷ Phipps, R.J.⁸ Burr, D.B.⁹

2
- 21044447888
- Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
- 5
- JY Reginster E Seeman MC De Vernejoul S Adami J Compston C Phenekos JP Devogelaer MD Curiel A Sawicki S Goemaere OH Sorensen D Felsenberg PJ Meunier 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 5 2816 2822
- (2005) J Clin Endocrinol Metab , vol.90 , pp. 2816-2822
- Reginster, J.Y.¹ Seeman, E.² De Vernejoul, M.C.³ Adami, S.⁴ Compston, J.⁵ Phenekos, C.⁶ Devogelaer, J.P.⁷ Curiel, M.D.⁸ Sawicki, A.⁹ Goemaere, S.¹⁰ Sorensen, O.H.¹¹ Felsenberg, D.¹² Meunier, P.J.¹³

3
- 33747875513
- Strontium ranelate: Vertebral and non-vertebral fracture risk reduction
- Suppl 1
- E Seeman 2006 Strontium ranelate: vertebral and non-vertebral fracture risk reduction Curr Opin Rheumatol 18 Suppl 1 S17 S20
- (2006) Curr Opin Rheumatol , vol.18
- Seeman, E.¹

4
- 9144233479
- The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
- 5
- PJ Meunier C Roux E Seeman S Ortolani JE Badurski TD Spector J Cannata A Balogh EM Lemmel S Pors-Nielsen R Rizzoli HK Genant JY Reginster 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 5 459 468
- (2004) N Engl J Med , vol.350 , pp. 459-468
- Meunier, P.J.¹ Roux, C.² Seeman, E.³ Ortolani, S.⁴ Badurski, J.E.⁵ Spector, T.D.⁶ Cannata, J.⁷ Balogh, A.⁸ Lemmel, E.M.⁹ Pors-Nielsen, S.¹⁰ Rizzoli, R.¹¹ Genant, H.K.¹² Reginster, J.Y.¹³

5
- 33645353336
- Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
- 4
- C Roux JY Reginster J Fechtenbaum S Kolta A Sawicki Z Tulassay G Luisetto JM Padrino D Doyle R Prince P Fardellone OH Sorensen PJ Meunier 2006 Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors J Bone Miner Res 21 4 536 542
- (2006) J Bone Miner Res , vol.21 , pp. 536-542
- Roux, C.¹ Reginster, J.Y.² Fechtenbaum, J.³ Kolta, S.⁴ Sawicki, A.⁵ Tulassay, Z.⁶ Luisetto, G.⁷ Padrino, J.M.⁸ Doyle, D.⁹ Prince, R.¹⁰ Fardellone, P.¹¹ Sorensen, O.H.¹² Meunier, P.J.¹³

6
- 0032722149
- Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
- 10
- LI Plotkin RS Weinstein AM Parfitt PK Roberson SC Manolagas T Bellido 1999 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin J Clin Invest 104 10 1363 1374
- (1999) J Clin Invest , vol.104 , pp. 1363-1374
- Plotkin, L.I.¹ Weinstein, R.S.² Parfitt, A.M.³ Roberson, P.K.⁴ Manolagas, S.C.⁵ Bellido, T.⁶

7
- 0003653295
- CRC Boca Raton
- Borchrd R, Barbes C, Eltherington L (1992) Drug dosage in laboratory animals. CRC, Boca Raton, p 514
- (1992) Drug Dosage in Laboratory Animals , pp. 514
- Borchrd, R.¹ Barbes, C.² Eltherington, L.³

8
- 0027316220
- An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
- 5
- PJ Marie M Hott D Modrowski C De Pollak J Guillemain P Deloffre Y Tsouderos 1993 An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J Bone Miner Res 8 5 607 615
- (1993) J Bone Miner Res , vol.8 , pp. 607-615
- Marie, P.J.¹ Hott, M.² Modrowski, D.³ De Pollak, C.⁴ Guillemain, J.⁵ Deloffre, P.⁶ Tsouderos, Y.⁷

9
- 18344379873
- Strontium ranelate: Dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial
- 5
- PJ Meunier DO Slosman PD Delmas JL Sebert ML Brandi C Albanese R Lorenc S Pors-Nielsen MC De Vernejoul A Roces JY Reginster 2002 Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial J Clin Endocrinol Metab 87 5 2060 2066
- (2002) J Clin Endocrinol Metab , vol.87 , pp. 2060-2066
- Meunier, P.J.¹ Slosman, D.O.² Delmas, P.D.³ Sebert, J.L.⁴ Brandi, M.L.⁵ Albanese, C.⁶ Lorenc, R.⁷ Pors-Nielsen, S.⁸ De Vernejoul, M.C.⁹ Roces, A.¹⁰ Reginster, J.Y.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.